VEEV241220P280000
- 47.50
- 0.000.00%
Veeva Systems Newsroom
Stephens Initiates Veeva Systems(VEEV.US) With Buy Rating, Announces Target Price $280
Express News | Veeva Systems Inc : Stephens Initiates Coverage With Overweight Rating; Target Price $280
Will Weakness in Veeva Systems Inc.'s (NYSE:VEEV) Stock Prove Temporary Given Strong Fundamentals?
ACRO Announces 2025 Officers and New Members
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
Veeva Systems Is Maintained at Underweight by Morgan Stanley
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Raises Target Price to $195
Morgan Stanley Sticks to Its Sell Rating for Veeva Systems (VEEV)
Here's Why You Should Retain Veeva Systems Stock in Your Portfolio Now
Veeva Systems Inc. (VEEV): A Bull Case Theory
8 Breakout Stocks to Watch – EA, FLUT, COMP, NET, and Others
Express News | JP Morgan Maintains Neutral on Veeva Systems, Raises Price Target to $218
If You Invested $1000 in Veeva Systems a Decade Ago, This Is How Much It'd Be Worth Now
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Conmed (CNMD) and Veeva Systems (VEEV)
Behind the "monthly salary over ten thousand": What are the "AI agents" that tech giants are competing to launch?
① OpenAI is open to launching a subscription service priced at "2000 dollars/month" and mentioned that in the future, it may charge enterprise users based on the value they gain from using AI; ② At the application level, "AI agents" are viewed as the products with the most straightforward commercialization logic due to their ability to "replace workers"; ③ Even though AI agents are still in the early stages, workers need to start thinking about where their future lies.
(VEEV) - Analyzing Veeva Systems's Short Interest
A Growing Number of Biopharmas Leverage Veeva Compass Patient to Improve Commercialization
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $183
Cautious Outlook on Veeva Systems Amidst Rising Competition and Customer Concerns
Customer attrition has led to a decline in Veeva (VEEV.US) stock prices. Baird reassures the market: the financial impact is manageable and maintains a "Shareholding" rating.
An executive from Veeva Systems, a Global provider of cloud solutions for the life sciences Industry, stated that a customer switched to Salesforce, causing the stock to drop by about 5% on Wednesday and eliciting reactions from Analysts.